Extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: Systematic review and meta‐analyses
Neurourology and Urodynamics · 2024
DOI: 10.1002/nau.25524 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Ivan Labetov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurourology department, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia. Hauptthemen laut MEDLINE: Chronic Pain, Extracorporeal Shockwave Therapy, Pelvic Pain, Prostatitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Saint Petersburg State University.
Abstract (Originalsprache)
Aims
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) prevalence varies from 8.4% to 25% of the male population and is associated with diminished health‐related quality of life. Managing CP/CPPS remains challenging and there is not any common option to treat all patients effectively because of the complex disease nature. The currently available data for the extracorporeal shockwave therapy (eSWT) effect on pain relief and well‐being were analyzed in the present study.
Methods
We adhered to PRISMA 2022 guidelines for reporting the quantitative and qualitative data synthesis. A literature search was conducted in March 2023 using PubMed/Medline, Scopus, and Google Scholar. Randomized prospective studies of eSWT alone or eSWT plus conventional medicinal treatment were included. The risk of bias was estimated using the RoB 2.0. Primary outcomes were self‐reported scores, including the NIH‐CPSI questionnaire and VAS, at 1 month or 2, 3, and 6, months follow‐up.
Results
The CP/CPPS patients who receive eSWT have more pronounced pain relief and improvement of other subjective NIH‐CPSI scores compared with control groups that received placebo or medication therapy. The effect of eSWT seems to be long‐lasting and was confirmed in the 6‐month follow‐up ( p < 0.01).
Conclusions
Based on the meta‐analysis of accessible studies, we receive the equivalence eSWT applicability for the CP/CPPS treatment and can be offered to patients because of its noninvasiveness, high level of safety, and successful clinical results demonstrated in this analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurourology department, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia.
- Institute of Translational Biomedicine, Saint-Petersburg State University, Saint-Petersburg, Russia.
ORCID-Profile: Ivan Labetov, Anastasia Vaganova, Gleb Kovalev, Dmitry Shkarupa
Förderung
- Saint Petersburg State University
Zitieren
APA
Labetov, I., Vaganova, A., Kovalev, G., & Shkarupa, D. (2024). Extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: Systematic review and meta‐analyses. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25524
Vancouver
Labetov I, Vaganova A, Kovalev G, Shkarupa D. Extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: Systematic review and meta‐analyses. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25524
BibTeX
@article{Labetov2024,
author = {Labetov, Ivan and Vaganova, Anastasia and Kovalev, Gleb and Shkarupa, Dmitry},
title = {Extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: Systematic review and meta‐analyses},
journal = {Neurourology and Urodynamics},
year = {2024},
doi = {10.1002/nau.25524}
}
EUVIMED